ClinicalTrials.Veeva

Menu

Balance Function in Patients Post Corona Virus Disease 2019 (COVID-19)

Duke University logo

Duke University

Status

Completed

Conditions

Covid19

Treatments

Other: Balance assessments

Study type

Observational

Funder types

Other

Identifiers

NCT04914364
Pro00108353

Details and patient eligibility

About

The purpose of this study is to describe balance deficits in patients post COVID-19. The information the investigators learn may help influence balance training exercises for patients post-COVID-19. Participants will have a primary or secondary diagnosis of COVID-19 during hospitalization and off COVID-19 isolation and be receiving care in an acute inpatient hospital. Following consent, participants will complete balance assessments and questionnaires about balance and dizziness in a single session. Vital signs will be monitored during the session.The greatest risks of this study include shortness of breath, and a risk of falling or musculoskeletal soreness.These risks are no greater than those experienced during a usual physical therapy visit.

Full description

Heart rate (HR), respiratory rate (RR), blood pressure (BP), and oxygen saturation (SpO2) will be measured at rest and after all outcome measures are completed. Rate of Perceived Exertion (RPE) (0-10 per modified Borg scale) will be measured after each outcome measure. In addition, HR will be measured after each outcome measure. SpO2 will be continually monitored via pulse oximetry. Fraction of inspired oxygen (FiO2) will be titrated per MD orders. If SpO2 drops below MD-specified parameters, patients will first be given a 3-minute seated rest break. If SpO2 recovers above MD-specified parameters after rest break, activity will resume. If SpO2 remains below MD-specified parameters after rest break or continues to drop with activity, FiO2 will be titrated to maintain SpO2 within MD-specified parameters.

Enrollment

28 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age > 18 years
  • Primary or secondary diagnosis of COVID- 19 during hospitalization and off COVID-19 isolation
  • Receiving care in acute inpatient
  • Ability to ambulate 20' with or without an assistive device without dropping >10% of resting oxygen saturation (determined from existing physical therapy evaluation)
  • Ability to stand with no more than contact guard assistance (determined from existing physical therapy evaluation)
  • Not requiring use of mechanical ventilation
  • Minimum resting oxygen saturation of 88% with or without supplemental oxygen
  • No neurological or orthopedic dysfunction that would affect balance
  • Cognitively intact and able to follow directions and provide consent

Exclusion criteria

  • History of 2 or more falls in the year prior to COVID-19 diagnosis or history of balance dysfunction

Trial design

28 participants in 1 patient group

Patients who have tested positive for COVID-19
Description:
Patients who are designated as "COVID recovered" in the electronic medical record and who fit the inclusion criteria.
Treatment:
Other: Balance assessments

Trial documents
1

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems